Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The neuronal norepinephrine transporter (NET), encoded by the SLC6A2 gene, is a transmembrane protein responsible for the reuptake of norepinephrine from the synaptic cleft back into presynaptic neurons. This process terminates noradrenergic signaling and plays a critical role in regulating mood, arousal, cognition, and autonomic function. NET is a therapeutic target for several classes of drugs, including antidepressants and psychostimulants, and dysregulation of NET has been implicated in various neuropsychiatric and cardiovascular disorders.
Inhibition of norepinephrine reuptake
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuronal norepinephrine transporter (NET).